Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.
Prostate cancer screening has resulted in earlier diagnosis with lower-grade disease, leading to over-detection and over-treatment in a significant number of patients. Current whole-gland radical treatments are associated with significant rates of morbidity. The high prevalence of low-risk disease together with an inability to accurately identify those men harboring more aggressive cancers has led to tremendous research in low-morbidity focal therapies for prostate cancer. This review summarizes the early experiences with focal therapy with emphasis on early applications of laser, high-intensity focuses ultrasound, and photodynamic approaches.
Written by:
Da Rosa MR, Trachtenberg J, Chopra R, Haider MA. Are you the author?
Reference: Cancer Imaging. 2011 Oct 3;11:S3-8.
doi: 10.1102/1470-7330.2011.9003
PubMed Abstract
PMID: 22187023
UroToday.com Prostate Cancer Section
